Skip to content

Egg shell derived Nano-hydroxyapatite as a regenerative material in Direct Sinus Augmentation.

Effect of Egg shell derived Nano-Hydroxyapatite (EnHA) in Direct Sinus Augmentation (DSA)- An Analytical Study. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070712
Enrollment
14
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Egg shell derived nano-hydroxyapatite: Egg shell derived nano-hydroxyapatite will be mixed with concentrated growth factor and will be grafted at the time of direct sinus augmentation p

Sponsors

DrVikrant Dilip Sane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Partially or completely edentulous posterior maxilla with residual height less than equal to 5mm. 2. 6 months gap between tooth extraction and implant placement. 3. Presence of healthy or restored adjacent teeth. 4. Patients with ASA category I or II. 5. Excellent oral hygiene.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled metabolic diseases, compromised immune system, haematological disorders, pregnancy, prior radiotherapy of maxillofacial region, chemotherapy, bone disease, medication or any other systemic illness which may affect prognosis of the treatment. 2. Radiographic evidence of maxillary sinus pathology. 3. History of sinusitis or maxillary sinus surgery. 4. Inadequate mouth opening. 5. Patients with habits of smoking, tobacco chewing, alcoholism, etc. 6. Patients not willing for egg shell derived graft material.

Design outcomes

Primary

MeasureTime frame
CBCT scan will be used to determine density of bone and level of alveolar bone height, histomorphometric analysis will be used to evaluate presence of residual graft material and replacement of grafted material by host bone alongwith any resorptive or inflammatory changes.Timepoint: 180 days

Secondary

MeasureTime frame
OPG will be taken to assess the stage of bone formation & clinical examination will be done to assess soft tissue healingTimepoint: 90 days

Countries

India

Contacts

Public ContactVikrant Dilip Sane

Bharati Vidyapeeth (Deemed to be) University Dental College and Hospital Pune

rajesh.kshirsagar@bharatividyapeeth.edu9822042097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026